生物活性 | |||
---|---|---|---|
描述 | TMPA is characterized as a high-affinity antagonist of Nur77, a mechanism that prompts the liberation and translocation of LKB1 into the cytoplasm, thereby activating AMPKα. This action has significant implications for diabetes management, as TMPA effectively reduces blood glucose levels and mitigates insulin resistance in various models of diabetes, including type II db/db, high-fat diet, and streptozotocin-induced diabetic mice. Furthermore, TMPA demonstrates potential therapeutic value in cancer and T-cell apoptosis regulation by diminishing restimulation-induced cell death (RICD) in human T cells[1][2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.63mL 0.53mL 0.26mL |
13.14mL 2.63mL 1.31mL |
26.28mL 5.26mL 2.63mL |
参考文献 |
---|